Understanding Parkinson’s Disease Clinical Trials for Black Americans

Parenting/ Health

Lifestyle / Parenting/ Health 35 Views 0 comments

Parkinson’s disease (PD) is the second most common neurodegenerative disorder in the world, after Alzheimer’s disease. Currently, nearly one million people in the United States have been diagnosed with Parkinson’s and that number is expected to further increase as the population ages. It is estimated that by 2030, 1.2 million Americans will be living with PD. “The main medication for PD, carbidopa/levodopa, was developed in the late 1960s/early 1970s and is still the primary medication used today. However, new therapies that may stop or halt PD symptoms are on the horizon and entering clinical trials,” James Beck PhD and Chief Scientific Officer (CSO) of the Parkinson’s Foundation, told BlackDoctor.org.  In his role as CSO, Dr. Beck oversees the research strategy of the Parkinson’s Foundation. He ensures that resources are directed effectively to have the maximum impact on halting the progression of the disease and improving the quality of life for individuals with Parkinson’s disease. What are Clinical Trials? Clinical trials are crucial for developing new treatments, providing essential data for regulatory approval, and enabling public access to potentially life-saving therapies. They offer eligible patients the opportunity to receive experimental treatments, advancing medical knowledge and potentially saving numerous lives. Clinical trials...

0 Comments